FILE PHOTO: A healthcare worker administers a dose of the "Comirnaty" Pfizer-BioNTech COVID-19 vaccine in a vaccination center in Antibes as part of the coronavirus disease vaccination campaign in France, March 29, 2021. REUTERS/Eric Gaillard
(Reuters) - There is a link between AstraZeneca's COVID-19 vaccine and very rare blood clots but the causes are still unknown, an official for the European Medicines Agency told an Italian newspaper. AstraZeneca declined to comment.
Meanwhile, coronavirus-related deaths worldwide passed 3 million.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
